BioPharmSignal logoBioPharmSignal

Biotech News

LifeStance Publishes Outcomes Data Validating the Benefit of Mental Health Treatment at Scale

LifeStance Health (LFST)LifeStance HealthCompany update

Analysis of 180,000 Patients Validates Measurement-Informed Care for Anxiety and Depression SCOTTSDALE, Ariz., April 9, 2026 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of outpatient mental health care, published new clinical outcomes data demonstrating that LifeStance

Related news

LFSTLifeStance Health2026-08-11 13:00 EST

LifeStance Survey Finds Women Want Mental Healthcare Built Into Perimenopause and Menopause Care

LFSTLifeStance Health2025-10-28 20:10 EST

LifeStance to Present at the UBS Global Healthcare Conference

View all latest news

LifeStance Health

Outpatient Mental Healthcare LifeStance Health is one of the largest U.S. providers of outpatient mental-health services for children, adolescents and adults. Its clinicians treat a broad range of behavioral-health conditions through therapy and psychiatric care. Hybrid Care Network The company combines in-person practices with virtual...

Recent company news

LFSTLifeStance Health2026-08-11 13:00 EST

LifeStance Survey Finds Women Want Mental Healthcare Built Into Perimenopause and Menopause Care

LFSTLifeStance Health2026-08-06 10:00 EST

LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook

LFSTLifeStance Health2026-07-16 20:10 EST

LifeStance to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026

LFSTLifeStance Health2026-05-08 02:18 EST

LifeStance Health Group Announces Pricing of Secondary Public Offering

LFSTLifeStance Health2026-05-07 20:51 EST

LifeStance Health Group Announces Launch of Secondary Public Offering

Stock data

Close
12.55 USD
Market cap
2.96B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States